Tnb 486 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tnb 486. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tnb 486 Today - Breaking & Trending Today

TNB-486 Elicits 91% CR Rate in Heavily Pretreated, High-Risk Follicular Lymphoma

Published: August 19, 2023

TNB-486 demonstrated sustained antitumor activity in all but 1 patient with relapsed/refractory follicular lymphoma, regardless of CD20 status, as well as number and type of prior therapy.

Source: onclive.com

Related Topics:

North CarolinaUnited StatesBryan JacobsTocilizumab ActemraLevine Cancer InstituteAtrium Health In CharlotteAtrium HealthAnn ArborTnb 486Patients With Relapsed Refractory Follicular LymphomaAtrium Health